Medicaid GLP-1 coverage by state: 2026

Weight-management coverage in every state

This is coverage under each state's fee-for-service Medicaid program, as surveyed by KFF, updated for changes reported since. Managed care plans generally follow the state's rules. Because coverage keeps changing, confirm with your state's preferred drug list or your plan.

• Alabama
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Alaska
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Arizona
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Arkansas
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• California
  Ended
  Ended for adults on January 1, 2026; diabetes and some other approved uses still covered.
• Colorado
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Connecticut
  Not covered
  Covers a weight-loss drug other than a GLP-1, per KFF.
• Delaware
  Covered, with prior authorization
  Among the 13 states KFF counted in January 2026.
• Florida
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Georgia
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Hawaii
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Idaho
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Illinois
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Indiana
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Iowa
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Kansas
  Covered, restricted
  Limited to people meeting severe-obesity criteria, with prior authorization.
• Kentucky
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Louisiana
  Not covered
  Covers a weight-loss drug other than a GLP-1, per KFF.
• Maine
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Maryland
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Massachusetts
  Ended
  Counted by KFF in January 2026; ongoing weight-management coverage ended in July 2026.
• Michigan
  Covered, restricted
  Since January 2026, limited to morbid obesity after other treatments have been tried.
• Minnesota
  Covered, with prior authorization
  Among the 13 states KFF counted in January 2026.
• Mississippi
  Covered, with prior authorization
  Among the 13 states KFF counted in January 2026.
• Missouri
  Covered, with prior authorization
  Added coverage; among the 13 states KFF counted in January 2026.
• Montana
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Nebraska
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Nevada
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• New Hampshire
  Ended
  Ended on January 1, 2026.
• New Jersey
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• New Mexico
  Not covered
  Covers a weight-loss drug other than a GLP-1, per KFF.
• New York
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• North Carolina
  Covered, with prior authorization
  Paused in October 2025 during a state budget stalemate and restored in December 2025.
• North Dakota
  Not covered
  Covers a weight-loss drug other than a GLP-1, per KFF.
• Ohio
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Oklahoma
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Oregon
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Pennsylvania
  Ended
  Ended on January 1, 2026.
• Rhode Island
  Covered, with prior authorization
  Among the 13 states KFF counted in January 2026.
• South Carolina
  Ended
  Ended on January 1, 2026.
• South Dakota
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Tennessee
  Covered, with prior authorization
  Added coverage from January 2026.
• Texas
  Not covered
  Covers a weight-loss drug other than a GLP-1, per KFF.
• Utah
  Covered, with prior authorization
  Added coverage; among the 13 states KFF counted in January 2026.
• Vermont
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Virginia
  Covered, restricted
  Criteria narrowed to people with the highest body mass index.
• Washington
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Washington, D.C.
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• West Virginia
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.
• Wisconsin
  Covered, with prior authorization
  Among the 13 states KFF counted in January 2026.
• Wyoming
  Not covered
  Not among the states KFF counted as covering GLP-1s for weight management.

What every Medicaid program must cover

Medicaid programs must cover nearly all FDA-approved medicines for their accepted medical uses, with a short list of optional exclusions that includes drugs for weight loss. So every state covers GLP-1s for type 2 diabetes, and states generally cannot exclude other approved uses, such as Wegovy to lower heart attack and stroke risk or Zepbound for obstructive sleep apnea, although they can require prior authorization. Only coverage for weight management on its own is a state choice.

What prior authorization usually requires

• A body mass index at or above the state’s threshold, sometimes with a weight-related condition such as high blood pressure or sleep apnea.
• Documentation of diet, activity or a structured weight-management program.
• For renewal, evidence of a minimum amount of weight lost by a set point.
• In some states, trying a preferred drug first, such as Wegovy before Zepbound or the reverse.

If your state does not cover it

You can ask whether another approved use applies to you, such as heart disease or sleep apnea, which Medicaid programs generally must cover with prior authorization. If a request is denied, you have the right to an appeal and a state fair hearing. Manufacturer copay cards cannot be used with Medicaid, but the manufacturers’ self-pay programs remain an option if you choose to pay yourself.

For how coverage works across other kinds of insurance, see GLP-1 coverage by insurance type, and for appeals, our guide to getting a GLP-1 covered.

Frequently asked questions

Related

• GLP-1 coverage by insurance type
• Getting a GLP-1 covered
• GLP-1 medications guide
• Pharmacy rules by state